Latest filing published 25 Sept 2026 for Harvard Apparatus Regenerative Technology, Inc., €618k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Junli He in Harvard Apparatus Regenerative Technology, Inc. The record holds 17 filings, for trades running from 12 December 2022 to 15 September 2026.
Both buying and selling appear: 15 purchases worth €471k, against 1 sale worth €876. Taken together, the purchases exceed the sales by €470k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 2 purchases and no sales on the market.
In size, the median ticket on the buying side is €7,576. On 3 out of 15 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 25 September 2026, the filings show a transaction worth €618k in Harvard Apparatus Regenerative Technology, Inc. The latest purchase is recent: it was published 23 days ago, on 25 September 2026. Typically, a trade is published a median of 10 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations